Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06011772
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2023-08-21
Brief Title:
EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Roswell Park Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-04
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-21
First Submit QC Date:
August 21 2023
Study First Post Date:
2023-08-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-02
Last Update Post Date:
2024-05-03
Last Update Post Date Type:
ACTUAL